| Dr Barbara Regina Herzig, MD | |
|
1137 Holland St, Birmingham, MI 48009-6849 | |
| (248) 644-3605 | |
| Not Available |
| Full Name | Dr Barbara Regina Herzig |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 27 Years |
| Location | 1137 Holland St, Birmingham, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336138965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301070550 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Birmingham Counseling Center Pc | 5092766022 | 3 |
News Archive
A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.
Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project (1kGP), selected to maximize its ability to detect new associations.
Cardiologists may soon be able to place sensitive electronics inside their patients' hearts with minimal invasiveness, enabling more sophisticated and efficient diagnosis and treatment of arrhythmias.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
› Verified 6 days ago
| Entity Name | Birmingham Counseling Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861608937 PECOS PAC ID: 5092766022 Enrollment ID: O20050207000678 |
News Archive
A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.
Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project (1kGP), selected to maximize its ability to detect new associations.
Cardiologists may soon be able to place sensitive electronics inside their patients' hearts with minimal invasiveness, enabling more sophisticated and efficient diagnosis and treatment of arrhythmias.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Regina Herzig, MD 1137 Holland St, Birmingham, MI 48009-6849 Ph: (248) 644-3605 | Dr Barbara Regina Herzig, MD 1137 Holland St, Birmingham, MI 48009-6849 Ph: (248) 644-3605 |
News Archive
A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.
Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project (1kGP), selected to maximize its ability to detect new associations.
Cardiologists may soon be able to place sensitive electronics inside their patients' hearts with minimal invasiveness, enabling more sophisticated and efficient diagnosis and treatment of arrhythmias.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
› Verified 6 days ago
Dr. Brian A Connolly, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 189 Townsend St, Ste 300, Birmingham, MI 48009 Phone: 248-642-3737 Fax: 248-642-1083 | |
Dr. Mufid B Al-najjar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 915 E Maple Rd, Birmingham, MI 48009 Phone: 248-642-3388 Fax: 248-642-0645 | |
Dr. Jolyn Welsh Wagner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 999 Haynes St, Suite 280, Birmingham, MI 48009 Phone: 248-258-9085 | |
Dr. Steven Ernst Nickoloff, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 555 S Old Woodward Ave, Suite 602, Birmingham, MI 48009 Phone: 248-594-6330 Fax: 248-594-7465 | |
Dr. Beth Goldman, M.D., M.P.H. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 55 W Maple Rd, Suite 206, Birmingham, MI 48009 Phone: 248-642-2320 | |
Dr. Howard Robert Belkin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1137 Holland St, Birmingham, MI 48009 Phone: 248-644-3605 |